ArticleFrontiers in microbiology2022
Genomic analysis of
Chantal Renau-Mínguez, Paula Herrero-Abadía, Paula Ruiz-Rodriguez, Vicente Sentandreu, Eduard Torrents, Álvaro Chiner-Oms, Manuela Torres-Puente, Iñaki Comas, Esther Julián, Mireia Coscolla
Open access · goldAbstract read
In one paragraphArticle in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 6 institutions in 1 country.
Chantal Renau-MínguezI2SysBio, University of Valencia-FISABIO Joint Unit, Paterna, Spain.
Paula Herrero-AbadíaGenetics and Microbiology Department, Faculty of Biosciences, Autonomous University of Barcelona, Barcelona, Spain.
Paula Ruiz-RodriguezI2SysBio, University of Valencia-FISABIO Joint Unit, Paterna, Spain.
Vicente SentandreuGenomics Unit, Central Service for Experimental Research (SCSIE), University of Valencia, Burjassot, Spain.
Eduard TorrentsBacterial Infections and Antimicrobial Therapies Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
Álvaro Chiner-OmsInstituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.
Manuela Torres-PuenteInstituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.
Iñaki ComasInstituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.
Esther JuliánGenetics and Microbiology Department, Faculty of Biosciences, Autonomous University of Barcelona, Barcelona, Spain.
Mireia CoscollaI2SysBio, University of Valencia-FISABIO Joint Unit, Paterna, Spain.
Instituto de Biomedicina de Valencia · ESUniversitat Autònoma de Barcelona · ESUniversitat de València · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESInstitute for Bioengineering of Catalonia · ESInstitute for Integrative Systems Biology · ES
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
diversityimmunogenicnon-pathogenicnontuberculous mycobacteriatherapeutic
Identifiers
PMID36687580
PMCPMC9850167
OpenAlexW4313562402
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390